These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 25983027)
1. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting. Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027 [TBL] [Abstract][Full Text] [Related]
2. Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions. Vlieger S; Simsek C; Balland A; Somi S; Jessurun G; Amoroso G; Kauer F; van Geuns RJ; IJsselmuiden A Catheter Cardiovasc Interv; 2019 Dec; 94(7):966-971. PubMed ID: 30903739 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry. Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875 [TBL] [Abstract][Full Text] [Related]
4. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions. Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462 [TBL] [Abstract][Full Text] [Related]
5. STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial. van Geuns RJ; Yetgin T; La Manna A; Tamburino C; Souteyrand G; Motreff P; Koch KT; Vrolix M; IJsselmuiden A; Amoroso G; Berland J; Montalescot G; Teiger E; Christiansen EH; Spaargaren R; Wijns W EuroIntervention; 2016 Feb; 11(11):e1267-74. PubMed ID: 26865444 [TBL] [Abstract][Full Text] [Related]
6. First-in-man (FIM) study of the Stentys bifurcation stent--30 days results. Verheye S; Grube E; Ramcharitar S; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Serruys PW; van Geuns RJ EuroIntervention; 2009 Mar; 4(5):566-71. PubMed ID: 19378675 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study. Amoroso G; van Geuns RJ; Spaulding C; Manzo-Silberman S; Hauptmann KE; Spaargaren R; García-García HM; Serruys PW; Verheye S EuroIntervention; 2011 Aug; 7(4):428-36. PubMed ID: 21764660 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry. Wańha W; Mielczarek M; Smolka G; Roleder T; Jaguszewski M; Ciećwierz D; Tomasiewicz B; Kubler P; Gorol J; Chmielecki M; Bartuś S; Navarese EP; Kasprzak M; Sukiennik A; Kubica J; Lekston A; Hawranek M; Reczuch K; Gruchała M; Ochała A; Wojakowski W Catheter Cardiovasc Interv; 2019 Mar; 93(4):574-582. PubMed ID: 30311397 [TBL] [Abstract][Full Text] [Related]
9. Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE study. Cortese B; Montefusco A; D'Ascenzo F; La Manna A; Andò G; Bisceglia T; Secco GG; Meyer-Gessner M; Wańha W; Sganzerla P; Napodano M; Di Palma G; Latini RA; Tamburino C; Orrego PS; Baumbach A Cardiovasc Revasc Med; 2018; 19(7 Pt B):831-836. PubMed ID: 29661597 [TBL] [Abstract][Full Text] [Related]
11. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study. Grundeken MJ; Lu H; Vos N; IJsselmuiden A; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; de Winter RJ; Wykrzykowska JJ; Amoroso G; Koch KT J Invasive Cardiol; 2017 Aug; 29(8):253-258. PubMed ID: 28756418 [TBL] [Abstract][Full Text] [Related]
12. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience. Montefusco A; De Filippo O; Gili S; Mancone M; Calcagno S; Cirillo P; Esposito G; Poli A; Ferrara E; Smolka G; Wanha W; Palmieri C; Pastormerlo LE; Baumbach A; Sganzerla P; Tamburino C; Bruno F; Secco GG; Nicolino A; Yew KL; di Palma G; Wojakowski W; Sardella G; Rinaldi M; Cortese B; D'Ascenzo F Coron Artery Dis; 2020 Jan; 31(1):27-34. PubMed ID: 31658146 [TBL] [Abstract][Full Text] [Related]
14. First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial. Qian J; Xu B; Lansky AJ; Yang YJ; Qiao SB; Wu YJ; Chen J; Hu FH; Yang WX; Mintz GS; Leon MB; Gao RL Chin Med J (Engl); 2012 Mar; 125(6):970-6. PubMed ID: 22613516 [TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort. Gaede L; Liebetrau C; Dörr O; Blumenstein J; Elsässer A; Hamm CW; Möllmann H; Schlundt C; Nef HM; Achenbach S Coron Artery Dis; 2017 Nov; 28(7):588-596. PubMed ID: 28704242 [TBL] [Abstract][Full Text] [Related]
16. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551 [TBL] [Abstract][Full Text] [Related]
17. The Glider registry. Secco GG; Rittger H; Hoffmann S; Richardt G; Abdel-Wahab M; Reinecke H; Lotan C; Werner G; Sievert H; Foin N; Di Mario C Catheter Cardiovasc Interv; 2017 Jan; 89(1):E1-E6. PubMed ID: 23729282 [TBL] [Abstract][Full Text] [Related]
18. Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial. Diletti R; Garcia-Garcia HM; Bourantas CV; van Geuns RJ; Van Mieghem NM; Agostoni P; Muramatsu T; Farooq V; Spencer R; De Schepper J; Pomeranz M; Stella P; Serruys PW EuroIntervention; 2013 May; 9(1):125-34. PubMed ID: 23685300 [TBL] [Abstract][Full Text] [Related]
19. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470 [TBL] [Abstract][Full Text] [Related]
20. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]